Cone dystrophy
diseaseOn this page
Also known as progressive cone dystrophystationary cone dystrophy
Summary
Cone dystrophy (MONDO:0000455) is a disease (an umbrella term covering 6 Mondo subtypes) with 31 cohort genes and 4 clinical trials. The dominant Reactome pathway is Inactivation, recovery and regulation of the phototransduction cascade (3 cohort genes).
At a glance
- Prevalence: Unknown (Worldwide)
- Umbrella term: 6 Mondo subtypes
- Cohort genes: 31
- ClinVar variants: 57
- Phenotypes (HPO): 5
- Clinical trials: 4
Clinical features
Signs & symptoms
Clinical features (HPO)
5 HPO clinical features (Orphanet curated; top 5 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000505 | Visual impairment | Very frequent (80-99%) |
| HP:0000512 | Abnormal electroretinogram | Very frequent (80-99%) |
| HP:0000551 | Color vision defect | Very frequent (80-99%) |
| HP:0000613 | Photophobia | Very frequent (80-99%) |
| HP:0007703 | Abnormality of retinal pigmentation | Very frequent (80-99%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | cone dystrophy |
| Mondo ID | MONDO:0000455 |
| MeSH | D000077765 |
| Orphanet | 1871 |
| DOID | DOID:0050795 |
| SNOMED CT | 312917007 |
| UMLS | C0730290 |
| MedGen | 676499 |
| GARD | 0011897 |
| NORD | 991 |
| Is cancer (heuristic) | no |
Also known as: cone dystrophy · progressive cone dystrophy · stationary cone dystrophy
Data availability: 57 ClinVar variants · 7 GenCC gene-disease records.
Disease family
An umbrella term covering 6 Mondo subtypes.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › retinal disorder › retinal degeneration › inherited retinal dystrophy › hereditary macular dystrophy › cone dystrophy
Related subtypes (16): vitelliform macular dystrophy, coloboma of macula, coloboma of macula-brachydactyly type B syndrome, benign concentric annular macular dystrophy, macular dystrophy, fenestrated sheen type, macular coloboma-cleft palate-hallux valgus syndrome, macular corneal dystrophy, EEM syndrome, renal hypomagnesemia 5 with ocular involvement, macular dystrophy, X-linked, AICA-ribosiduria, occult macular dystrophy, familial flecked retinopathy, patterned dystrophy of the retinal pigment epithelium, macular dystrophy, retinal, macular dystrophy with or without cone dysfunction
Subtypes (6): retinal cone dystrophy type 1, cone dystrophy, X-linked, with tapetal-like sheen, cone dystrophy 3, cone dystrophy with supernormal rod response, retinal cone dystrophy 4, cone dystrophy 4
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
57 retrieved; paginated sample, class counts are floors:
20 pathogenic, 14 conflicting classifications of pathogenicity, 11 pathogenic/likely pathogenic, 7 likely pathogenic, 4 uncertain significance, 1 likely benign
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 634547 | NM_000350.3(ABCA4):c.5172G>A (p.Trp1724Ter) | ABCA4 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 7888 | NM_000350.3(ABCA4):c.5882G>A (p.Gly1961Glu) | ABCA4 | Pathogenic | reviewed by expert panel |
| 813135 | NM_000350.3(ABCA4):c.3583_3584insGT (p.Leu1195fs) | ABCA4 | Pathogenic | criteria provided, single submitter |
| 813137 | NM_000350.3(ABCA4):c.4635del (p.Ser1545_Leu1546insTer) | ABCA4 | Pathogenic | criteria provided, single submitter |
| 813147 | NM_000350.3(ABCA4):c.2588-7_2588-5delinsGG | ABCA4 | Pathogenic | criteria provided, single submitter |
| 865769 | NM_000350.3(ABCA4):c.6005+1G>A | ABCA4 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 99476 | NM_000350.3(ABCA4):c.6658C>T (p.Gln2220Ter) | ABCA4 | Pathogenic | reviewed by expert panel |
| 560424 | NM_001042472.3(ABHD12):c.447G>A (p.Trp149Ter) | ABHD12 | Pathogenic | no assertion criteria provided |
| 438047 | NM_145200.5(CABP4):c.673C>T (p.Arg225Ter) | CABP4 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 194793 | NM_033100.4(CDHR1):c.2522_2528del (p.Ile841fs) | CDHR1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2364 | NM_201548.5(CERKL):c.769C>T (p.Arg257Ter) | CERKL | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 523393 | NM_201548.5(CERKL):c.481+2T>G | CERKL | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 428573 | NM_004928.3(CFAP410):c.218G>C (p.Arg73Pro) | CFAP410 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 438156 | NM_001298.3(CNGA3):c.1405G>A (p.Ala469Thr) | CNGA3 | Pathogenic | criteria provided, single submitter |
| 813040 | NM_001298.3(CNGA3):c.625T>C (p.Ser209Pro) | CNGA3 | Pathogenic | criteria provided, single submitter |
| 39614 | NM_201253.3(CRB1):c.2843G>A (p.Cys948Tyr) | CRB1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 623278 | NM_001377295.2(GNAT2):c.620A>T (p.Glu207Val) | GNAT2 | Pathogenic | criteria provided, single submitter |
| 9355 | NM_000180.4(GUCY2D):c.2512C>T (p.Arg838Cys) | GUCY2D | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 9357 | NM_000180.4(GUCY2D):c.2513G>A (p.Arg838His) | GUCY2D | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 265419 | NM_133497.4(KCNV2):c.778A>T (p.Lys260Ter) | KCNV2 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 813184 | NM_133497.4(KCNV2):c.1186G>T (p.Gly396Ter) | KCNV2 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 813186 | NM_133497.4(KCNV2):c.1356+3_1356+6del | KCNV2 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 438390 | NM_022787.4(NMNAT1):c.271G>A (p.Glu91Lys) | NMNAT1 | Pathogenic/Likely pathogenic | no assertion criteria provided |
| 813199 | NM_031220.4(PITPNM3):c.1657_1660dup (p.Tyr554Ter) | PITPNM3 | Pathogenic | criteria provided, single submitter |
| 13183 | NM_000322.5(PRPH2):c.424C>T (p.Arg142Trp) | PRPH2 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 813080 | NM_000322.5(PRPH2):c.686_689del (p.Asn229fs) | PRPH2 | Pathogenic | criteria provided, single submitter |
| 9910 | NM_001034853.2(RPGR):c.3096_3097del (p.Glu1033fs) | RPGR | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 9911 | NM_001034853.2(RPGR):c.3092_3093del (p.Glu1031fs) | RPGR | Pathogenic | reviewed by expert panel |
| 813234 | NM_020366.4(RPGRIP1):c.2432T>A (p.Leu811His) | RPGRIP1 | Pathogenic | criteria provided, single submitter |
| 96125 | NM_024592.5(SRD5A3):c.57G>A (p.Trp19Ter) | SRD5A3 | Pathogenic | criteria provided, multiple submitters, no conflicts |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 43 · Orphanet: 67 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| GUCA1A | Definitive | Autosomal dominant | cone-rod dystrophy 14 | 8 |
| PDE6C | Definitive | Autosomal recessive | cone dystrophy 4 | 6 |
| RP1L1 | Definitive | Autosomal dominant | occult macular dystrophy | 11 |
| IRX5 | Moderate | Autosomal dominant | cone dystrophy | 6 |
| IRX6 | Moderate | Autosomal dominant | cone dystrophy | |
| CNGB3 | Supportive | Autosomal dominant | cone dystrophy | 5 |
| GNAT2 | Supportive | Autosomal dominant | cone dystrophy | 6 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| GNAT2 | Orphanet:1871 | Progressive cone dystrophy |
| GNAT2 | Orphanet:49382 | Achromatopsia |
| PDE6C | Orphanet:1871 | Progressive cone dystrophy |
| PDE6C | Orphanet:49382 | Achromatopsia |
| IRX5 | Orphanet:314555 | Facial dysmorphism-ocular anomalies-osteopenia-intellectual disability-dental anomalies syndrome |
| RP1L1 | Orphanet:247834 | Occult macular dystrophy |
| RP1L1 | Orphanet:791 | Retinitis pigmentosa |
| CNGB3 | Orphanet:1871 | Progressive cone dystrophy |
| CNGB3 | Orphanet:49382 | Achromatopsia |
| CNGB3 | Orphanet:827 | Stargardt disease |
| GUCA1A | Orphanet:1871 | Progressive cone dystrophy |
| GUCA1A | Orphanet:1872 | Cone rod dystrophy |
| GUCA1A | Orphanet:75377 | Central areolar choroidal dystrophy |
| RPGR | Orphanet:1872 | Cone rod dystrophy |
| RPGR | Orphanet:244 | Primary ciliary dyskinesia |
| RPGR | Orphanet:247522 | Primary ciliary dyskinesia-retinitis pigmentosa syndrome |
| RPGR | Orphanet:49382 | Achromatopsia |
| RPGR | Orphanet:791 | Retinitis pigmentosa |
| SAG | Orphanet:75382 | Oguchi disease |
| SAG | Orphanet:791 | Retinitis pigmentosa |
| CFAP410 | Orphanet:1872 | Cone rod dystrophy |
| CFAP410 | Orphanet:653709 | Cone rod dystrophy-short stature syndrome |
| CFAP410 | Orphanet:803 | Amyotrophic lateral sclerosis |
| RPGRIP1 | Orphanet:1872 | Cone rod dystrophy |
| RPGRIP1 | Orphanet:564 | Meckel syndrome |
| RPGRIP1 | Orphanet:65 | Leber congenital amaurosis |
| CABP4 | Orphanet:714070 | Incomplete congenital stationary night blindness, Schubert-Bornschein type |
| CABP4 | Orphanet:98784 | Sleep-related hypermotor epilepsy |
| CDHR1 | Orphanet:1872 | Cone rod dystrophy |
| CDHR1 | Orphanet:791 | Retinitis pigmentosa |
| ABHD12 | Orphanet:171848 | Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome |
| NMNAT1 | Orphanet:1872 | Cone rod dystrophy |
| NMNAT1 | Orphanet:65 | Leber congenital amaurosis |
| WDR19 | Orphanet:1515 | Cranioectodermal dysplasia |
| WDR19 | Orphanet:3156 | Senior-Loken syndrome |
| WDR19 | Orphanet:474 | Jeune syndrome |
| WDR19 | Orphanet:93592 | Juvenile nephronophthisis |
| KCNV2 | Orphanet:209932 | Cone dystrophy with supernormal rod response |
| CACNA2D4 | Orphanet:1872 | Cone rod dystrophy |
| CACNA2D4 | Orphanet:714070 | Incomplete congenital stationary night blindness, Schubert-Bornschein type |
| PITPNM3 | Orphanet:1872 | Cone rod dystrophy |
| CNGA3 | Orphanet:1872 | Cone rod dystrophy |
| CNGA3 | Orphanet:49382 | Achromatopsia |
| CERKL | Orphanet:791 | Retinitis pigmentosa |
| CRB1 | Orphanet:251295 | Pigmented paravenous retinochoroidal atrophy |
| CRB1 | Orphanet:35612 | Nanophthalmos |
| CRB1 | Orphanet:65 | Leber congenital amaurosis |
| CRB1 | Orphanet:791 | Retinitis pigmentosa |
| SRD5A3 | Orphanet:324737 | SRD5A3-CDG |
| ABCA4 | Orphanet:1872 | Cone rod dystrophy |
Cohort genes → proteins
31 cohort genes, 31 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 31 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| GNAT2 | HGNC:4394 | ENSG00000134183 | P19087 | Guanine nucleotide-binding protein G(t) subunit alpha-2 | gencc,clinvar |
| PDE6C | HGNC:8787 | ENSG00000095464 | P51160 | Cone cGMP-specific 3’,5’-cyclic phosphodiesterase subunit alpha' | gencc,clinvar |
| IRX5 | HGNC:14361 | ENSG00000176842 | P78411 | Iroquois-class homeodomain protein IRX-5 | gencc |
| IRX6 | HGNC:14675 | ENSG00000159387 | P78412 | Iroquois-class homeodomain protein IRX-6 | gencc |
| RP1L1 | HGNC:15946 | ENSG00000183638 | Q8IWN7 | Retinitis pigmentosa 1-like 1 protein | gencc |
| CNGB3 | HGNC:2153 | ENSG00000170289 | Q9NQW8 | Cyclic nucleotide-gated channel beta-3 | gencc |
| GUCA1A | HGNC:4678 | ENSG00000048545 | P43080 | Guanylyl cyclase-activating protein 1 | gencc |
| RNF7 | HGNC:10070 | ENSG00000114125 | Q9UBF6 | RING-box protein 2 | clinvar |
| RPGR | HGNC:10295 | ENSG00000156313 | Q92834 | X-linked retinitis pigmentosa GTPase regulator | clinvar |
| SAG | HGNC:10521 | ENSG00000130561 | P10523 | S-arrestin | clinvar |
| CFAP410 | HGNC:1260 | ENSG00000160226 | O43822 | Cilia- and flagella-associated protein 410 | clinvar |
| RPGRIP1 | HGNC:13436 | ENSG00000092200 | Q96KN7 | X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 | clinvar |
| CABP4 | HGNC:1386 | ENSG00000175544 | P57796 | Calcium-binding protein 4 | clinvar |
| CDHR1 | HGNC:14550 | ENSG00000148600 | Q96JP9 | Cadherin-related family member 1 | clinvar |
| ABHD12 | HGNC:15868 | ENSG00000100997 | Q8N2K0 | Lysophosphatidylserine lipase ABHD12 | clinvar |
| NMNAT1 | HGNC:17877 | ENSG00000173614 | Q9HAN9 | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 | clinvar |
| WDR19 | HGNC:18340 | ENSG00000157796 | Q8NEZ3 | WD repeat-containing protein 19 | clinvar |
| KCNV2 | HGNC:19698 | ENSG00000168263 | Q8TDN2 | Potassium voltage-gated channel subfamily V member 2 | clinvar |
| CACNA2D4 | HGNC:20202 | ENSG00000151062 | Q7Z3S7 | Voltage-dependent calcium channel subunit alpha-2/delta-4 | clinvar |
| PITPNM3 | HGNC:21043 | ENSG00000091622 | Q9BZ71 | Membrane-associated phosphatidylinositol transfer protein 3 | clinvar |
| CNGA3 | HGNC:2150 | ENSG00000144191 | Q16281 | Cyclic nucleotide-gated channel alpha-3 | clinvar |
| CERKL | HGNC:21699 | ENSG00000188452 | Q49MI3 | Ceramide kinase-like protein | clinvar |
| CRB1 | HGNC:2343 | ENSG00000134376 | P82279 | Protein crumbs homolog 1 | clinvar |
| SRD5A3 | HGNC:25812 | ENSG00000128039 | Q9H8P0 | Polyprenal reductase | clinvar |
| RGL4 | HGNC:31911 | ENSG00000159496 | Q8IZJ4 | Ral-GDS-related protein | clinvar |
| ABCA4 | HGNC:34 | ENSG00000198691 | P78363 | Retinal-specific phospholipid-transporting ATPase ABCA4 | clinvar |
| GUCY2D | HGNC:4689 | ENSG00000132518 | Q02846 | Retinal guanylyl cyclase 1 | clinvar |
| BBS5 | HGNC:970 | ENSG00000163093 | Q8N3I7 | BBSome complex member BBS5 | clinvar |
| RAB28 | HGNC:9768 | ENSG00000157869 | P51157 | Ras-related protein Rab-28 | clinvar |
| PRPH2 | HGNC:9942 | ENSG00000112619 | P23942 | Peripherin-2 | clinvar |
| RGR | HGNC:9990 | ENSG00000148604 | P47804 | RPE-retinal G protein-coupled receptor | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| GNAT2 | Guanine nucleotide-binding protein G(t) subunit alpha-2 | Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. |
| PDE6C | Cone cGMP-specific 3’,5’-cyclic phosphodiesterase subunit alpha' | As cone-specific cGMP phosphodiesterase, it plays an essential role in light detection and cone phototransduction by rapidly decreasing intracellular levels of cGMP. |
| IRX5 | Iroquois-class homeodomain protein IRX-5 | Establishes the cardiac repolarization gradient by its repressive actions on the KCND2 potassium-channel gene. |
| IRX6 | Iroquois-class homeodomain protein IRX-6 | Transcription factor. |
| RP1L1 | Retinitis pigmentosa 1-like 1 protein | Required for the differentiation of photoreceptor cells. |
| CNGB3 | Cyclic nucleotide-gated channel beta-3 | Pore-forming subunit of the cone cyclic nucleotide-gated channel. |
| GUCA1A | Guanylyl cyclase-activating protein 1 | Stimulates retinal guanylyl cyclase when free calcium ions concentration is low and inhibits guanylyl cyclase when free calcium ions concentration is elevated. |
| RNF7 | RING-box protein 2 | Catalytic component of multiple cullin-5-RING E3 ubiquitin-protein ligase complexes (ECS complexes), which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. |
| RPGR | X-linked retinitis pigmentosa GTPase regulator | Acts as a guanine-nucleotide releasing factor (GEF) for RAB8A and RAB37 by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP. |
| SAG | S-arrestin | Binds to photoactivated, phosphorylated RHO and terminates RHO signaling via G-proteins by competing with G-proteins for the same binding site on RHO. |
| CFAP410 | Cilia- and flagella-associated protein 410 | Plays a role in cilia formation and/or maintenance. |
| RPGRIP1 | X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 | May function as scaffolding protein. |
| CABP4 | Calcium-binding protein 4 | Involved in normal synaptic function through regulation of Ca(2+) influx and neurotransmitter release in photoreceptor synaptic terminals and in auditory transmission. |
| CDHR1 | Cadherin-related family member 1 | Potential calcium-dependent cell-adhesion protein. |
| ABHD12 | Lysophosphatidylserine lipase ABHD12 | Lysophosphatidylserine (LPS) lipase that mediates the hydrolysis of lysophosphatidylserine, a class of signaling lipids that regulates immunological and neurological processes. |
| NMNAT1 | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 | Catalyzes the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP. |
| WDR19 | WD repeat-containing protein 19 | As component of the IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs), it is involved in cilia function and/or assembly. |
| KCNV2 | Potassium voltage-gated channel subfamily V member 2 | Potassium channel subunit. |
| CACNA2D4 | Voltage-dependent calcium channel subunit alpha-2/delta-4 | The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel. |
| PITPNM3 | Membrane-associated phosphatidylinositol transfer protein 3 | Catalyzes the transfer of phosphatidylinositol and phosphatidylcholine between membranes (in vitro). |
| CNGA3 | Cyclic nucleotide-gated channel alpha-3 | Pore-forming subunit of the cone cyclic nucleotide-gated channel. |
| CERKL | Ceramide kinase-like protein | Has no detectable ceramide-kinase activity. |
| CRB1 | Protein crumbs homolog 1 | Plays a role in photoreceptor morphogenesis in the retina. |
| SRD5A3 | Polyprenal reductase | Plays a key role in early steps of protein N-linked glycosylation by being involved in the conversion of polyprenol into dolichol. |
| ABCA4 | Retinal-specific phospholipid-transporting ATPase ABCA4 | Flippase that catalyzes in an ATP-dependent manner the transport of retinal-phosphatidylethanolamine conjugates like 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine (N-Ret-PE) from the lumen to the cytoplasmic leafl… |
| GUCY2D | Retinal guanylyl cyclase 1 | Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors. |
| BBS5 | BBSome complex member BBS5 | The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. |
| RAB28 | Ras-related protein Rab-28 | The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. |
| PRPH2 | Peripherin-2 | Essential for retina photoreceptor outer segment disk morphogenesis, may also play a role with ROM1 in the maintenance of outer segment disk structure. |
| RGR | RPE-retinal G protein-coupled receptor | Receptor for all-trans- and 11-cis-retinal. |
Protein-family classification
Druggable: 9 · Difficult: 5 · Unknown: 17 · Druggable fraction: 0.29
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Ion channel | 3 | 10.8× | 0.019 |
| Transporter | 1 | 2.5× | 0.579 |
| Kinase | 2 | 1.8× | 0.579 |
| Transcription factor | 5 | 1.3× | 0.579 |
| Other/Unknown | 17 | 1.0× | 0.743 |
| Enzyme (other) | 2 | 0.8× | 0.743 |
| GPCR | 1 | 0.8× | 0.743 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| GNAT2 | Other/Unknown | no | Gprotein_alpha_su, Gprotein_alpha_I, GproteinA_insert | |
| PDE6C | Transcription factor | no | PDEase_catalytic_dom, GAF, HD/PDEase_dom | |
| IRX5 | Transcription factor | no | HD, Iroquois_homeo, KN_HD | |
| IRX6 | Transcription factor | no | HD, Iroquois_homeo, KN_HD | |
| RP1L1 | Other/Unknown | no | Doublecortin_dom, Doublecortin_dom_sf | |
| CNGB3 | Ion channel | yes | cNMP-bd_dom, Ion_trans_dom, RmlC-like_jellyroll | |
| GUCA1A | Other/Unknown | no | EF_hand_dom, EF-hand-dom_pair, EF_Hand_1_Ca_BS | |
| RNF7 | Transcription factor | no | Znf_RING, Znf_RING/FYVE/PHD, Znf_RING_H2 | |
| RPGR | Other/Unknown | no | Reg_chr_condens, RCC1/BLIP-II, Signaling_Regulatory_Domain | |
| SAG | Other/Unknown | no | Arrestin, Arrestin-like_N, Arrestin-like_C | |
| CFAP410 | Other/Unknown | no | Leu-rich_rpt, U2A’_phosphoprotein32A_C, LRR_dom_sf | |
| RPGRIP1 | Other/Unknown | no | C2_dom, C2-C2_1, RPGRIP1_fam | |
| CABP4 | Other/Unknown | no | EF_hand_dom, EF-hand-dom_pair, EF_Hand_1_Ca_BS | |
| CDHR1 | Other/Unknown | no | Cadherin-like_dom, Cadherin-like_sf, Cadherin_CS | |
| ABHD12 | Other/Unknown | no | AB_hydrolase_1, AB_hydrolase_fold | |
| NMNAT1 | Enzyme (other) | yes | 2.7.7.1 | Cyt_trans-like, NadD/NMNAT, Rossmann-like_a/b/a_fold |
| WDR19 | Transcription factor | no | WD40_rpt, TPR-like_helical_dom_sf, WD40/YVTN_repeat-like_dom_sf | |
| KCNV2 | Ion channel | yes | T1-type_BTB, K_chnl_volt-dep_Kv, K_chnl_volt-dep_Kv5/Kv9 | |
| CACNA2D4 | Other/Unknown | no | VWF_A, VWA_N, VDCC_a2/dsu | |
| PITPNM3 | Other/Unknown | no | PI_transfer, DDHD_dom, HAD_sf | |
| CNGA3 | Ion channel | yes | cNMP-bd_dom, Ion_trans_dom, RmlC-like_jellyroll | |
| CERKL | Kinase | yes | Diacylglycerol_kinase_cat_dom, NAD/diacylglycerol_kinase_sf, ATP-NAD_kinase_N | |
| CRB1 | Other/Unknown | no | EGF-type_Asp/Asn_hydroxyl_site, EGF, Laminin_G | |
| SRD5A3 | Enzyme (other) | yes | 1.3.1.22 | 3-oxo-5_a-steroid_4-DH_C, Dfg10/SRD5A3 |
| RGL4 | Other/Unknown | no | RASGEF_cat_dom, Ras-like_GEF, Ras_GEF_dom_sf | |
| ABCA4 | Transporter | yes | ABC_transporter-like_ATP-bd, AAA+_ATPase, ABCA4/ABCR | |
| GUCY2D | Kinase | yes | 4.6.1.2 | Prot_kinase_dom, A/G_cyclase, Ser-Thr/Tyr_kinase_cat_dom |
| BBS5 | Other/Unknown | no | BBL5, PH-like_dom_sf, BBS5_PH | |
| RAB28 | Other/Unknown | no | Small_GTPase, Small_GTP-bd, P-loop_NTPase | |
| PRPH2 | Other/Unknown | no | Peripherin/rom-1, Tetraspanin_EC2_sf, Peripherin/rom-1_CS | |
| RGR | GPCR | yes | GPCR_Rhodpsn, RPE_GPCR, GPCR_Rhodpsn_7TM |
Expression context
Cohort genes with no expression data: 0.
28 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 31 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | 7 |
| primordial germ cell in gonad | 4 |
| right uterine tube | 4 |
| bronchial epithelial cell | 3 |
| skin of abdomen | 3 |
| hindlimb stylopod muscle | 3 |
| pigmented layer of retina | 3 |
| sperm | 3 |
| endothelial cell | 3 |
| olfactory segment of nasal mucosa | 3 |
| secondary oocyte | 2 |
| bone marrow cell | 2 |
| buccal mucosa cell | 2 |
| nucleus accumbens | 2 |
| left testis | 2 |
| adenohypophysis | 2 |
| ganglionic eminence | 2 |
| ventricular zone | 2 |
| oocyte | 1 |
| cerebellar hemisphere | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| GNAT2 | 153 | tissue_specific | marker | oocyte, primordial germ cell in gonad, secondary oocyte |
| PDE6C | 159 | tissue_specific | marker | secondary oocyte, male germ line stem cell (sensu Vertebrata) in testis, cerebellar hemisphere |
| IRX5 | 163 | broad | marker | upper leg skin, bronchial epithelial cell, skin of abdomen |
| IRX6 | 95 | tissue_specific | marker | apex of heart, skin of abdomen, hindlimb stylopod muscle |
| RP1L1 | 30 | tissue_specific | yes | primordial germ cell in gonad, buccal mucosa cell, bone marrow cell |
| CNGB3 | 161 | tissue_specific | marker | male germ line stem cell (sensu Vertebrata) in testis, pigmented layer of retina, diaphragm |
| GUCA1A | 52 | broad | marker | nucleus accumbens, putamen, hypothalamus |
| RNF7 | 292 | ubiquitous | marker | left adrenal gland, left adrenal gland cortex, right adrenal gland |
| RPGR | 281 | ubiquitous | marker | sperm, bronchial epithelial cell, right uterine tube |
| SAG | 106 | tissue_specific | marker | nucleus accumbens, male germ line stem cell (sensu Vertebrata) in testis, left testis |
| CFAP410 | 190 | ubiquitous | marker | right uterine tube, adenohypophysis, right frontal lobe |
| RPGRIP1 | 168 | tissue_specific | marker | left testis, sperm, right testis |
| CABP4 | 226 | broad | marker | vena cava, cardia of stomach, ventral tegmental area |
| CDHR1 | 186 | broad | marker | upper arm skin, skin of leg, skin of abdomen |
| ABHD12 | 256 | ubiquitous | marker | C1 segment of cervical spinal cord, prefrontal cortex, spinal cord |
| NMNAT1 | 225 | ubiquitous | yes | hindlimb stylopod muscle, muscle of leg, mucosa of transverse colon |
| WDR19 | 269 | ubiquitous | marker | right uterine tube, bronchial epithelial cell, adenohypophysis |
| KCNV2 | 61 | tissue_specific | marker | sperm, male germ cell, primordial germ cell in gonad |
| CACNA2D4 | 136 | broad | yes | monocyte, leukocyte, granulocyte |
| PITPNM3 | 222 | broad | marker | pancreatic ductal cell, endothelial cell, Brodmann (1909) area 23 |
| CNGA3 | 110 | tissue_specific | marker | ventricular zone, male germ line stem cell (sensu Vertebrata) in testis, ganglionic eminence |
| CERKL | 122 | tissue_specific | marker | islet of Langerhans, olfactory segment of nasal mucosa, male germ line stem cell (sensu Vertebrata) in testis |
| CRB1 | 163 | broad | marker | ganglionic eminence, ventricular zone, endothelial cell |
| SRD5A3 | 254 | ubiquitous | marker | palpebral conjunctiva, gall bladder, olfactory segment of nasal mucosa |
| RGL4 | 155 | broad | marker | bone marrow, bone marrow cell, blood |
| ABCA4 | 164 | tissue_specific | marker | pigmented layer of retina, primordial germ cell in gonad, male germ line stem cell (sensu Vertebrata) in testis |
| GUCY2D | 121 | tissue_specific | marker | buccal mucosa cell, esophagus mucosa, lower esophagus mucosa |
| BBS5 | 140 | ubiquitous | marker | right uterine tube, male germ line stem cell (sensu Vertebrata) in testis, olfactory segment of nasal mucosa |
| RAB28 | 284 | ubiquitous | marker | tibia, germinal epithelium of ovary, endothelial cell |
| PRPH2 | 176 | tissue_specific | marker | quadriceps femoris, vastus lateralis, hindlimb stylopod muscle |
Protein interactions among cohort
Intra-cohort edges: 54.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| RNF7 | 2,453 |
| NMNAT1 | 2,424 |
| RPGR | 2,231 |
| SAG | 1,927 |
| KCNV2 | 1,908 |
| CABP4 | 1,897 |
| GNAT2 | 1,675 |
| RAB28 | 1,563 |
| IRX6 | 1,533 |
| ABCA4 | 1,532 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| ABCA4 | CDHR1 | string_interaction |
| ABCA4 | CERKL | string_interaction |
| ABCA4 | CNGB3 | string_interaction |
| ABCA4 | GUCY2D | string_interaction |
| ABCA4 | KCNV2 | string_interaction |
| ABCA4 | PITPNM3 | string_interaction |
| ABCA4 | PRPH2 | string_interaction |
| ABCA4 | RGR | string_interaction |
| ABCA4 | RP1L1 | string_interaction |
| ABCA4 | RPGR | string_interaction |
| CABP4 | CACNA2D4 | string_interaction |
| CACNA2D4 | KCNV2 | string_interaction |
| CDHR1 | CERKL | string_interaction |
| CDHR1 | GUCY2D | string_interaction |
| CDHR1 | KCNV2 | string_interaction |
| CDHR1 | PITPNM3 | string_interaction |
| CDHR1 | PRPH2 | string_interaction |
| CDHR1 | RAB28 | string_interaction |
| CDHR1 | RPGRIP1 | string_interaction |
| CERKL | RGR | string_interaction |
| CERKL | RP1L1 | string_interaction |
| CERKL | RPGR | string_interaction |
| CNGA3 | CNGB3 | biogrid_interaction, string_interaction |
| CNGA3 | GNAT2 | string_interaction |
| CNGA3 | GUCY2D | string_interaction |
| CNGA3 | KCNV2 | string_interaction |
| CNGA3 | PDE6C | string_interaction |
| CNGA3 | RPGR | string_interaction |
| CNGB3 | GNAT2 | string_interaction |
| CNGB3 | GUCY2D | string_interaction |
| CNGB3 | KCNV2 | string_interaction |
| CNGB3 | PDE6C | string_interaction |
| CNGB3 | RPGR | string_interaction |
| CNGB3 | RPGRIP1 | string_interaction |
| GNAT2 | PDE6C | string_interaction |
| GUCA1A | GUCY2D | string_interaction |
| GUCA1A | RPGRIP1 | string_interaction |
| GUCY2D | KCNV2 | string_interaction |
| GUCY2D | NMNAT1 | string_interaction |
| GUCY2D | PDE6C | string_interaction |
| GUCY2D | PITPNM3 | string_interaction |
| GUCY2D | PRPH2 | string_interaction |
| GUCY2D | RPGRIP1 | string_interaction |
| IRX5 | IRX6 | string_interaction |
| KCNV2 | PDE6C | string_interaction |
| KCNV2 | RPGRIP1 | string_interaction |
| PITPNM3 | RAB28 | string_interaction |
| PITPNM3 | RPGRIP1 | string_interaction |
| PRPH2 | RP1L1 | string_interaction |
| PRPH2 | RPGR | string_interaction |
Structural data
PDB: 16 · AlphaFold-only: 15 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| CNGA3 | Q16281 | 10 |
| CNGB3 | Q9NQW8 | 9 |
| ABCA4 | P78363 | 8 |
| PDE6C | P51160 | 7 |
| RNF7 | Q9UBF6 | 7 |
| NMNAT1 | Q9HAN9 | 6 |
| WDR19 | Q8NEZ3 | 4 |
| RPGR | Q92834 | 3 |
| GNAT2 | P19087 | 2 |
| RAB28 | P51157 | 2 |
| CFAP410 | O43822 | 1 |
| RPGRIP1 | Q96KN7 | 1 |
| PITPNM3 | Q9BZ71 | 1 |
| CRB1 | P82279 | 1 |
| BBS5 | Q8N3I7 | 1 |
| PRPH2 | P23942 | 1 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| RGR | P47804 | 90.04 |
| SRD5A3 | Q9H8P0 | 89.07 |
| ABHD12 | Q8N2K0 | 85.60 |
| SAG | P10523 | 85.44 |
| GUCY2D | Q02846 | 82.37 |
| CACNA2D4 | Q7Z3S7 | 81.69 |
| CERKL | Q49MI3 | 79.82 |
| CDHR1 | Q96JP9 | 78.79 |
| KCNV2 | Q8TDN2 | 75.55 |
| GUCA1A | P43080 | 71.28 |
| CABP4 | P57796 | 65.01 |
| RGL4 | Q8IZJ4 | 62.88 |
| IRX6 | P78412 | 55.29 |
| IRX5 | P78411 | 55.14 |
| RP1L1 | Q8IWN7 | 38.97 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 53. Enrichment computed across 31 evidence-associated genes (14 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 14 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Inactivation, recovery and regulation of the phototransduction cascade | 3 | 68.0× | 5e-04 | SAG, GUCA1A, GUCY2D |
| Defective SRD5A3 causes SRD5A3-CDG, KHRZ | 1 | 815.7× | 0.017 | SRD5A3 |
| Defective visual phototransduction due to ABCA4 loss of function | 1 | 815.7× | 0.017 | ABCA4 |
| Visual phototransduction | 2 | 37.1× | 0.017 | SAG, ABCA4 |
| Diseases associated with glycosylation precursor biosynthesis | 1 | 407.9× | 0.026 | SRD5A3 |
| Retinoid cycle disease events | 1 | 203.9× | 0.032 | ABCA4 |
| Diseases associated with visual transduction | 1 | 203.9× | 0.032 | ABCA4 |
| Diseases of the neuronal system | 1 | 203.9× | 0.032 | ABCA4 |
| Synthesis of PI | 1 | 163.1× | 0.032 | PITPNM3 |
| Arachidonate production from DAG | 1 | 163.1× | 0.032 | ABHD12 |
| Synthesis of dolichyl-phosphate | 1 | 116.5× | 0.041 | SRD5A3 |
| Sensory Perception | 2 | 13.6× | 0.041 | SAG, ABCA4 |
| The phototransduction cascade | 1 | 90.6× | 0.042 | SAG |
| Opsins | 1 | 90.6× | 0.042 | RGR |
| Androgen biosynthesis | 1 | 74.2× | 0.047 | SRD5A3 |
| Activation of the phototransduction cascade | 1 | 68.0× | 0.048 | SAG |
| Metabolism of steroid hormones | 1 | 37.1× | 0.078 | SRD5A3 |
| The canonical retinoid cycle in rods (twilight vision) | 1 | 37.1× | 0.078 | ABCA4 |
| BBSome-mediated cargo-targeting to cilium | 1 | 35.5× | 0.078 | BBS5 |
| Effects of PIP2 hydrolysis | 1 | 32.6× | 0.079 | ABHD12 |
| Inactivation of CSF3 (G-CSF) signaling | 1 | 31.4× | 0.079 | RNF7 |
| Nicotinate metabolism | 1 | 28.1× | 0.084 | NMNAT1 |
| Synthesis of substrates in N-glycan biosythesis | 1 | 20.9× | 0.108 | SRD5A3 |
| G alpha (i) signalling events | 2 | 5.6× | 0.108 | GNAT2, RGR |
| Cargo trafficking to the periciliary membrane | 1 | 17.7× | 0.114 | BBS5 |
| Voltage gated Potassium channels | 1 | 17.4× | 0.114 | KCNV2 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 1 | 14.8× | 0.128 | SRD5A3 |
| Intraflagellar transport | 1 | 14.3× | 0.128 | WDR19 |
| Ca2+ pathway | 1 | 12.8× | 0.134 | GNAT2 |
| Hedgehog ‘off’ state | 1 | 12.8× | 0.134 | WDR19 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 31 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| visual perception | 15 | 38.5× | 8e-19 | GNAT2, PDE6C, RPGR, RPGRIP1, CABP4, IRX5, RP1L1, CNGA3 (+7 more) |
| photoreceptor cell outer segment organization | 4 | 135.9× | 1e-06 | CDHR1, RP1L1, CRB1, PRPH2 |
| detection of light stimulus involved in visual perception | 4 | 83.6× | 7e-06 | GNAT2, CACNA2D4, CRB1, PRPH2 |
| phototransduction | 4 | 64.0× | 2e-05 | GNAT2, CABP4, GUCA1A, RGR |
| retinal cone cell development | 3 | 135.9× | 4e-05 | GNAT2, PDE6C, CABP4 |
| photoreceptor cell maintenance | 4 | 46.3× | 4e-05 | CDHR1, RP1L1, CRB1, ABCA4 |
| photoreceptor cell morphogenesis | 2 | 181.2× | 1e-03 | CABP4, CDHR1 |
| retinal bipolar neuron differentiation | 2 | 181.2× | 1e-03 | CABP4, IRX5 |
| phototransduction, visible light | 2 | 83.6× | 0.004 | PDE6C, ABCA4 |
| retina development in camera-type eye | 3 | 24.7× | 0.004 | RP1L1, CNGA3, PRPH2 |
| gonad development | 2 | 72.5× | 0.005 | IRX5, WDR19 |
| cellular response to light stimulus | 2 | 68.0× | 0.005 | CRB1, RGR |
| cell development | 2 | 57.2× | 0.007 | IRX5, IRX6 |
| monoatomic cation transport | 2 | 49.4× | 0.008 | CNGA3, CNGB3 |
| cilium assembly | 4 | 9.5× | 0.008 | RPGR, CFAP410, WDR19, BBS5 |
| monoatomic cation transmembrane transport | 2 | 40.3× | 0.011 | CNGA3, CNGB3 |
| embryonic cranial skeleton morphogenesis | 2 | 37.5× | 0.012 | IRX5, WDR19 |
| response to low light intensity stimulus | 1 | 543.6× | 0.014 | PRPH2 |
| polyprenol catabolic process | 1 | 543.6× | 0.014 | SRD5A3 |
| positive regulation of guanylate cyclase activity | 1 | 543.6× | 0.014 | GUCA1A |
| camera-type eye photoreceptor cell development | 1 | 543.6× | 0.014 | CRB1 |
| post-embryonic retina morphogenesis in camera-type eye | 1 | 271.8× | 0.024 | CRB1 |
| inorganic cation import across plasma membrane | 1 | 271.8× | 0.024 | CNGA3 |
| background adaptation | 1 | 271.8× | 0.024 | GNAT2 |
| phospholipid transfer to membrane | 1 | 181.2× | 0.031 | ABCA4 |
| homeostasis of number of retina cells | 1 | 181.2× | 0.031 | GNAT2 |
| establishment of bipolar cell polarity involved in cell morphogenesis | 1 | 181.2× | 0.031 | CRB1 |
| phosphatidylserine catabolic process | 1 | 135.9× | 0.031 | ABHD12 |
| photoreceptor cell development | 1 | 135.9× | 0.031 | RP1L1 |
| ear morphogenesis | 1 | 135.9× | 0.031 | WDR19 |
Therapeutics
Drug target analysis
Approved (phase 4): 3 · Phase ≥3: 3 · Phased (≥1): 3 · Undrugged: 28
Druggability breadth: 7 of 31 evidence-associated genes (23%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Genes with an approved drug
The molecule shown is one approved compound that hits the gene — not necessarily a drug of choice or one indicated for this disease.
| Symbol | Example approved molecule |
|---|---|
| PDE6C | VARDENAFIL |
| ABHD12 | ORLISTAT |
| CACNA2D4 | NIMODIPINE |
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| PDE6C | 6 | 4 |
| ABHD12 | 2 | 4 |
| CACNA2D4 | 2 | 4 |
| GNAT2 | 0 | 0 |
| IRX5 | 0 | 0 |
| IRX6 | 0 | 0 |
| RP1L1 | 0 | 0 |
| CNGB3 | 0 | 0 |
| GUCA1A | 0 | 0 |
| RNF7 | 0 | 0 |
Drugs targeting cohort genes (top 30)
| Molecule | Max phase | Targets in cohort |
|---|---|---|
| VARDENAFIL | 4 | PDE6C |
| SILDENAFIL | 4 | PDE6C |
| TADALAFIL | 4 | PDE6C |
| DIPYRIDAMOLE | 4 | PDE6C |
| ORLISTAT | 4 | ABHD12 |
| DRONABINOL | 4 | ABHD12 |
| NIMODIPINE | 4 | CACNA2D4 |
| TACRINE | 4 | CACNA2D4 |
| ZAPRINAST | 2 | PDE6C |
| TBA-7371 | 2 | PDE6C |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 3.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| PDE6C | 103 | Binding:97, ADMET:6 |
| ABHD12 | 35 | Binding:31, Toxicity:3, ADMET:1 |
| KCNV2 | 21 | Binding:20, Toxicity:1 |
| CACNA2D4 | 13 | Binding:13 |
| NMNAT1 | 3 | Binding:3 |
| CFAP410 | 1 | Binding:1 |
| SRD5A3 | 1 | Binding:1 |
Cohort enzymes (BRENDA EC)
| Symbol | EC numbers | Names |
|---|---|---|
| NMNAT1 | 2.7.7.1, 2.7.7.18 | nicotinamide-nucleotide adenylyltransferase, nicotinate-nucleotide adenylyltransferase |
| SRD5A3 | 1.3.1.22, 1.3.1.94, 1.3.1.B13 | 3-oxo-5alpha-steroid 4-dehydrogenase (NADP+), polyprenal reductase, |
| GUCY2D | 4.6.1.2 | guanylate cyclase |
Cohort genes with high screening signal
≥100 ChEMBL assays — a studied-ness signal; see Therapeutics for approved-drug status.
| Symbol | ChEMBL assays |
|---|---|
| PDE6C | 103 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 31; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
10 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
| Compound | Max phase | Cohort target (bioactivity) |
|---|---|---|
| VARDENAFIL | 4 | PDE6C |
| SILDENAFIL | 4 | PDE6C |
| TADALAFIL | 4 | PDE6C |
| DIPYRIDAMOLE | 4 | PDE6C |
| ORLISTAT | 4 | ABHD12 |
| DRONABINOL | 4 | ABHD12 |
| NIMODIPINE | 4 | CACNA2D4 |
| TACRINE | 4 | CACNA2D4 |
| ZAPRINAST | 2 | PDE6C |
| TBA-7371 | 2 | PDE6C |
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 3 | PDE6C, ABHD12, CACNA2D4 |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 4 | CNGB3, NMNAT1, CNGA3, ABCA4 |
| D | Druggable family + AlphaFold only, no drug | 5 | KCNV2, CERKL, SRD5A3, GUCY2D, RGR |
| E | Difficult family or no structure, no drug | 19 | GNAT2, IRX5, IRX6, RP1L1, GUCA1A, RNF7, RPGR, SAG, CFAP410, RPGRIP1 (+9 more) |
Undrugged target profiles
28 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| GNAT2 | 0 | PDE6C |
| CNGB3 | 0 | PDE6C |
| CNGA3 | 0 | PDE6C |
| IRX5 | 0 | — |
| IRX6 | 0 | — |
| RP1L1 | 0 | — |
| GUCA1A | 0 | — |
| RNF7 | 0 | — |
| RPGR | 0 | — |
| SAG | 0 | — |
| CFAP410 | 1 | — |
| RPGRIP1 | 0 | — |
| CABP4 | 0 | — |
| CDHR1 | 0 | — |
| NMNAT1 | 3 | — |
| WDR19 | 0 | — |
| KCNV2 | 21 | — |
| PITPNM3 | 0 | — |
| CERKL | 0 | — |
| CRB1 | 0 | — |
| SRD5A3 | 1 | — |
| RGL4 | 0 | — |
| ABCA4 | 0 | — |
| GUCY2D | 0 | — |
| BBS5 | 0 | — |
| RAB28 | 0 | — |
| PRPH2 | 0 | — |
| RGR | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 4.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 4 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02435940 | Not specified | RECRUITING | Inherited Retinal Degenerative Disease Registry |
| NCT05355415 | Not specified | RECRUITING | Adaptive Optics Imaging of Outer Retinal Diseases |
| NCT03990727 | Not specified | UNKNOWN | Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies. |
| NCT04658251 | Not specified | TERMINATED | Study of New Mutations in Cone Disorders |